Skip to main content

Table 3 Subgroup analyses of n-3 LC-PUFAs supplementation during pregnancy on the incidence of allergic asthma

From: A dose-response meta-analysis of the association between the maternal omega-3 long-chain polyunsaturated fatty acids supplement and risk of asthma/wheeze in offspring

allergic asthma

Subgroup classification

Number of studies

RR (95% CI)

P

I2 (%)

 

<  5 years

2

0.43 (0.19, 0.99)

0.047

0

Age of offspring*

5–18 years

2

0.45 (0.05, 3.99)

0.47

87.7

 

>  18 years

1

0.27 (0.08, 0.91)

0.04

/

  1. RR Risk ratio, CI Confidential interval, P is for statistical significance of the subgroup results. I2 is for statistical heterogeneity within studies